Gallagher’s Directors & Officers’ (D&O) Insurance Guide provides crucial insights to help safeguard leadership teams from potential legal and financial liabilities.

In the highly regulated and fast-paced life sciences industry, the stakes are high for decision-makers. One misstep could put your company’s assets—and your personal assets—at risk.

The guide supports organisations in the life sciences sector by offering the following:

  • Tailored for life sciences: Understand the specific risks your industry faces and how to mitigate them effectively.
  • Comprehensive coverage insights: Learn about essential coverage considerations that help protect your directors and officers from potential liabilities and risks.
  • Real-world scenarios: Discover how D&O insurance can help protect against real-life threats like regulatory investigations, shareholder actions, and more.

To download the guide, visit Gallagher’s website.

Latest Opportunities

Single manufacturer & supplier required for human skin patch: Formulation, manufacture, and packing

Opportunity Company:  Nottingham-based MedTech company Requires: Seeking a single manufacturer and supplier for the formulation,…

Medilink Midlands Job Vacancy - Innovation Adviser

About the job Innovation Adviser – Midlands region – Full time salary £40-45K – Home…

Global Business Innovation Programme: Health & Medical Technologies - Singapore

Innovate UK is inviting ambitious innovative companies to participate in its Global Business Innovation Programme…

Latest News

Cambridge Sleep Sciences Unveils World-First Performance Pillow That Adapts to Users’ Sleep

Cambridge Sleep Sciences Unveils World-First Performance Pillow That Adapts to Users’ Sleep – Helping Gamers…

Kindeva Opens New UK HQ and Manufacturing Site for the Development of Next-Generation Propellants

Kindeva, a global CDMO and drug delivery expert, has officially opened its new UK headquarters…

EU MDR/IVDR Revision: A Gateway for Chinese Innovators Entering UK and EU Markets via EFEC

In a significant move for the global medtech landscape, the European Commission has initiated a…